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ABSTRACT
There has been no previous prevalence study about of Sjögren’s syndrome (SS) in Brazil. The aim was to evaluate the SS 
prevalence in a general population in Vitória, ES, Brazil. This was an epidemiological, observational, and cross-sectional 
study conducted on 1,205 randomized people, aged 18–65 years, who lived in Vitória. The subjects were screened for 
xerostomia and xerofphthalmia through home interviews. Those with sicca symptoms were asked to report to a hospital 
for further medical evaluation, unstimulated salivary À ow, Schirmer I test, blood analysis and minor labial salivary biopsy. 
Sicca symptoms were found in 18% (217 subjects) of the sample. Of the 217 subjects with sicca symptoms, 127 (58%) 
were available for examination. In this sample, 61.7% were female and 46.8% were under medication. Sicca syndrome 
was con¿ rmed in 12% by at least one examination (salivary À ow or Schirmer I). Two patients (0.17%) matched four 
criteria according to American-European Criteria (95% CI = 0.020–0.5983).  
Keywords: primary Sjögren syndrome, prevalence, minor salivary biopsy, epidemiology.
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INTRODUCTION
Primary Sjögren’s syndrome (pSS) is an autoimmune sys-
temic disease characterized not only by lymphocytic in¿ l-
tration of exocrine glands, but also by its effect on some 
organs like lungs, nerves, blood, and kidneys.1 Its symptom 
is usually presented by dryness of the mouth and eyes.2 
The pSS is one of the most common autoimmune diseases. 
But it has a low rate of diagnosis because dry complaints are 
not systematically investigated by physicians.3
Published studies of pSS prevalence have shown different 
results, ranging from 0.04% to 4.8%.4–14These differences 
can be explained because of the use of different diagnostic 
criteria, tests, and reference values to assess the dysfunction 
of lachrymal and salivary glands. Another reason could be that 
many studies were performed in different countries including 
those on speci¿ c populations.
Over the years, many different criteria have been pro-
posed: Boston (1965), Japanese (1971), San Francisco (1975), 
Copenhagen (1976), San Diego (1986), Greek (1986), and 
European (1993). The currently accepted criteria are those of 
the American-European Consensus Group (2002).15 The main 
contributions and differences of those criteria include: the 
San Francisco Criteria, which proposed histological criteria 
for salivary biopsy; the San Diego Criteria, which included 
SS-A and/or SS-B autoantibodies as required criteria, the 
European Criteria, which considered antinuclear antibod-
ies, rheumatoid factor, and lachrymal biopsy as criteria. In 
general, the criteria developed by the American scienti¿ c 
committee took into account speci¿ c and objective tests like 
biopsy and autoantibodies. On the other hand, the European 
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criteria emphasized on clinical dryness symptoms. Based 
on the European criteria, it was possible to classify people 
with only sicca symptoms and dysfunctional lachrymal and 
salivary tests as SS. The American-European classi¿ cation 
criteria maintained the same clinical questions and tests 
for glandular dysfunction for screening of dryness. Also, it 
included requirement of positive biopsy or anti-SS-A/SS-B 
to ful¿ ll diagnosis.15
Using the preliminary European criteria,16 the estimated 
prevalence in women living in a rural community in Greece 
was 0.6%.4 Similar results were found for those in Slovenia 
(0.6%) and Denmark (0.6%–2.1%).10,11 Using the Copenhagen 
criteria, the prevalence was 2.7% in Sweden and 0.7% in 
China.6,12 In a study conducted in the USA by Hochberg 
(1996), the prevalence was 0.04% for those aged between 65 
and 84 years. This low rate is because autoantibodies were 
used to classify the patients.13 In others studies the preva-
lence of SS was between 2% and 4.8%.5,12,15 In the United 
Kingdom, the prevalence was estimated to be 3%–4%, using 
the preliminary European criteria.8 Using the American-
European consensus, the prevalence rates are ranging from 
0.1% to 0.4%.9
There has been no previous study about SS prevalence in 
Brazil. Hence, the objective of this study was to determine the 
pSS prevalence in a Brazilian city, using a randomized sample.
MATERIAL AND METHODS
This study was an epidemiological, observational, and cross-
sectional one on 1,205 randomized subjects, aged 18–65 
years, who lived in Vitória, the capital of Espírito Santo 
State, located in the southeast region of Brazil. Vitória is an 
island, with an area of 93,381 km2 surrounded by mangroves; 
40% is mountainous with tropical climate, and has an annual 
average temperature of around 23 °C. In 2010, the popula-
tion was around 320,156 inhabitants and 95% of adults were 
literate. There is a mix of different ethnic groups in Brazil, 
including indigenous, blacks, and Caucasians (Portuguese, 
French, German, and Italian people).
 The sample was proportional to the 2000 demographic 
census data of the Brazilian Institute of Geography and 
Statistics (IBGE, in Portuguese). It was probabilistic, by 
conglomerates, multiple stages within homogeneous strata 
with the sampling unit being the domicile. In the socioeco-
nomic class de¿ nition, the monthly revenue of the head of 
the household is expressed in ranges based on minimum 
wage (MW). These ranges are the following: up to 2 MW 
(US$ 318.00), from 2 to 5 MW (US$ 318.00 to 795.00), 
from 5 to 10 MW (US$ 795.00 to 1,590.00), and more than 
10 MW (US$ 1,590.00). The average obtained was 7.5 MW 
(US$ 1,193.18) with a standard deviation of 4.55 MW 
(US$ 723.86). Adopting a procedure where the size of the 
sample is proportional to the population, and considering 
the population size as in¿ nite (large), the desired precision 
of 0.7%, and a signi¿ cance level of 5%, the sample size was 
calculated to be 1,158 individuals. At the end of the study, 
the con¿ dence interval was calculated on the basis of the 
derived result.
During the ¿ rst part of the study, randomized home visits 
were performed. About six standard questions (sicca symp-
toms) from the American-European criteria15 were asked. 
The interviewers were undergraduate health-care students 
who were trained to conduct these interviews.
The choice of households was randomized according to 
the following criteria: domiciled unit located on the farthest 
right side of the map, on the right side of the street. The way 
to be followed was always by the right, clockwise, and then 
skipping three houses between each visited one. The choice 
of the person in the house to be included in the interview was 
also randomized according to gender, age, and date of birth.
In the second phase, all patients were evaluated by a 
rheumatologist medical doctor. Complementary exams 
were performed to investigate rheumatic disease, including 
Schirmer test, unstimulated salivary À ow, rheumatoid factor, 
antinuclear antibodies (ANA), anti-SS-A/Ro, anti-SS-B/La, 
and salivary lip biopsy. Patients with positive HIV/HTLV 
tests and lymphoma were excluded. 
Unstimulated whole salivary À ow in 15 min was collected 
in the morning (8–10 h) and stored in clean plastic contain-
ers. The sample was weighed in a precision balance. It was 
considered that saliva has 1 mg to each 1 mL. Patients were 
instructed not to eat food or drink beverages with caffeine, or 
smoke, or chew bubble gum on the day of the examination. 
Room temperature was maintained between 20 °C and 30 ºC, 
and air conditioning was turned off.
Blood samples were collected and stored at í20 ºC for 
autoantibody identi¿ cation, virus C, and HIV analysis. All 
individuals were asked to undergo salivary lip biopsy.17 The 
salivary glands were formalin-¿ xed until histopathological 
analysis was performed by an expert pathologist. In minor 
salivary glands (obtained through normal-appearing mucosa) 
focal lymphocytic sialoadenitis, with a focus score 1, de¿ ned 
as a number of lymphocytic foci (which contain more than 50 
lymphocytes) per 4 mm2 of glandular tissue was considered 
as SS. Patients who had dry eyes or dry mouth symptoms 
plus positive autoantibody (SS-A or SS-B) or 1 focus score 
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were considered positive for SS. Also, patients who ful¿ lled 
four-criteria (out of the six) were classi¿ ed as SS according 
to the American-European criteria.15
Characteristics of the population were described. The chi-
square test was used to compare patients with and without 
dryness symptoms. For the quantitative variables, Student 
t-test was used. For the ones with non-normal distributions, 
Mann-Whitney test was used. For all tests, the signifi-
cance level was 5%. To evaluate data normal distribution, 
Kolmogorov-Smirnoff test was performed. 
The study had approval from the Research Ethics 
Committee of the Universidade Federal do Espírito Santo, 
and all participants were informed about the research and 
had given their written informed consent.
RESULTS
A total of 1,205 participants were interviewed and were 
representative of the general population of Vitória city. All 
individuals accepted to answer questionnaires and to com-
plete the ¿ rst stage (Figure 1). In this sample, 50.8% were 
women, 45.3% were married, 47.5% were Caucasian, aged 
36.2 (13.6) years (Table 1). After home screening for sicca 
syndrome, 18% (217) of the participants showed oral or visual 
dryness. The most common complaint was the sensation or 
feeling of having sand or gravel in the eyes followed by dry 
mouth. Out of the 217 individuals, 58% (127) were evaluated 
for Schirmer test, unstimulated whole salivary À ow, blood 
analysis, and minor labial salivary biopsy. Several reasons for 
nonperformance of the examinations were observed: forgot 
to follow up, change of address, lack of time, or had given up 
on examinations. Only one patient disagreed to undergo all.
Trying to understand any bias that could have happened, 
the 90 individuals with sicca symptoms who were not avail-
able for examinations (second phase) were compared with 
those 127 who had undergone tests, including salivary lip 
biopsy. Participants who came to examination were older 
(44.77 ± 13.1 vs. 36.1 ± 13.5; P = 0.001; t test). No other 
statistical difference was found (Table 2).
At least one positive test for dryness was observed in 
12% of the participants. Visual dryness without oral mani-
festation was observed in 41.1% and isolated oral dryness 
in only 24.4%.
In the ¿ nal analysis, two individuals have achieved at 
least four criteria and could be classi¿ ed as SS according 
American-European criteria. Thus, the prevalence observed 
was 0.17% (CI = 0.0201–0.05983) (Figure 1). Both Sjögren 
patients were female, non-white, and married; one was 41 
years old and the other, 46 years old. One was using medica-
tion and both did not have comorbidities (Table 3). 
DISCUSSION
This study provided the ¿ rst Brazilian data about pSS preva-
lence. Brazil has a continental extension and it would be very 
hard to perform this methodology and design for all states. 
The mixed-race ethnic groups of Vitória city represent the 
most important ethnicities of Brazilian population. 
Table 1
Demographic characteristics of the sample
Variable Category Count %
Gender FemaleMale
614
591
51.0
49.0%
Ethnicity*
Caucasian
Black
Indigenous
Mixed origin
554
207
2
403
47.5
17.8
0.2
34.6
Marital status*
Single
Married
Widow
Divorced
513
534
42
90
43.5
45.3
3.6
7.6
Social class*
A
B
C
D
359
322
445
60
30.3
27.2
37.5
5.0
Variable Mean SD Min–max
Age 36.2 13.6 18–65
n = 1,205. The differences correspond to information loss. SD = standard deviation.
1,205 individuals were 
interviewed (home visits)
90 did not undergo the lip 
biopsy and other exams
127 were included in 2nd Phase and 
underwent complementary exams 
including lip biopsy (58%)
0.17% was classiﬁed as Sjögren’s 
Syndrome according American-
European Criteria
988 without any sicca 
symptoms (82%)
217 with sicca 
symptoms (18%)
2 patients fulﬁlled 
at least 4 criteria
Figure 1
Flowchart of the sample.
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Many studies were performed in different countries, 
including speci¿ c populations, like old people and patients 
of outpatient rheumatology clinic.4í9,13,14 However, there 
has been no previous study in the Brazilian population. 
Prevalence studies have shown different results. The large 
variability could be explained by differences in genetic and 
environmental factors, but primarily it may also reÀ ect on 
differences in the methodology. The prevalence found, of 
0.17%, agrees with that observed in other studies that have 
used American-European criteria.9 
Many classi¿ cation criteria for SS had been proposed, 
modi¿ ed, and revised before and during the International 
Symposia in Copenhagen in 1986.13 Nowadays, in spite of 
some limitations, the American-European Consensus is used 
widely to classify SS.15 These criteria have included oral 
and visual dryness associated with sialoadenitis or positive 
autoantibodies (SS-A/Ro and SS-B/La).
Table 2
Demographic and sicca symptoms comparisons between individuals that have performed exams in second phase compared to 
others who did not perform tests (non-participants second phase)
Variable Category
Non-participants 2nd phase Performed tests
P*
n Col % n Col %
Gender FemaleMale
57
35
62
38
79
45
63.7
36.3 0.903
Ethnicity
Caucasian
Black
Mixed origin
34
24
33
37.4
26.4
36.3
51
21
47
42.9
17.6
39.5
0.307
Marital status
Single
Married
Widow
Divorced
24
52
7
8
26.4
57.1
7.7
8.8
49
61
6
5
40.5
50.4
5
4.1
0.115
Sicca symptom
(answer yes) 
- Have you had daily, persistent, troublesome 
dry eyes for more than 3 months?
- Do you have a recurrent sensation of sand 
or gravel in the eyes?
- Do you use tear substitutes more than 
3 times a day?
- Have you had a daily feeling of dry mouth 
for more than 3 months?
- Have you had recurrently or persistently 
swollen salivary glands as a3?
- Do you frequently drink liquids to aid in 
swallowing dry food?
35
29
13
48
5
19
37.6
31.2
14
51.6
5.4
20.4
38
48
16
55
7
30
30.6
38.7
12.9
48.4
5.7
24.4
0.281
0.251
0.818
0.289
0.920
0.512
*Chi-square test.
Table 3
Classi¿ cation criteria for primary Sjögren’s syndrome in patients
Criteria number Ocular dryness Mouth dryness Schirmer test Salivary ﬂ ow Medicine Ro/La ≥ 1 focus score/4 mm2
4 Yes Yes Pos 4,269 Yes Neg Yes
4 Yes Yes Pos 2,868 No Neg Yes
Medicine = antihypertensives, antidepressants, diuretics. Schirmer (mm/5 min); Salivary ﬂ ow (mL/15 min).
In the sample, only two individuals ful¿ lled at least four 
criteria classi¿ ed as SS. It is possible that patients with three 
or two criteria including positive lip biopsy can be classi¿ ed 
as SS in the future. Being strict in requiring four positive ¿ nd-
ings to diagnose pSS, according to the American-European 
consensus, those mild, atypical, and initial diseases might 
have been excluded. The rigor of the current criteria, insidi-
ous disease onset, and wide spectrum of systemic clinical 
manifestation could underestimate the prevalence.
It was a limitation of the study not performing all 
complementary exams included in the American-European 
consensus. Perhaps, individuals with negative Schirmer test 
or normal salivary À ow could present other positive dry tests 
like Bengal Rose, scintigraphy, and sialography. Unstimulated 
salivary À ow and Schirmer test were chosen because they 
are easy and cheap to perform. In addition, these tests have 
shown good correlation and sensitivity for SS diagnosis.18
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Among the interviewed patients without dryness symp-
toms (988 from 1,205), it could be possible to find SS 
because the sicca syndrome cannot be present in early SS 
and in patients with a predominance of systemic symptoms. 
However, this dif¿ culty is related to aspects of SS disease 
and limitation of classi¿ cation criteria, which explains how 
hard it is to carry out randomized clinical trials.
Another limitation of the study was that only 58% of the 
invited individuals came to the second phase, i.e., for sali-
vary biopsy and autoantibody evaluation. A prevalence of 
SS considering only participants of second phase that came 
to complementary exams could result in an under-estimate 
of SS in the population as a whole. This limitation is also 
present in other studies.5–9 People who performed exams 
were older than nonparticipants of the second phase of the 
study. Perhaps, older people are more responsible or have a 
better understanding of the importance of the study. Also, it 
is possible and expected that the nonparticipants have had 
milder dryness. That’s why we believe that the prevalence 
would not be so higher if all individuals with dryness were 
included in the second phase of the study. 
 Previous studies failed to determine histological ab-
normalities because many patients disagreed to submit for 
biopsy.4–14 However, disagree to invasive exams is common 
in large population studies. A positive point of this study 
was that biopsy was done for all participants with dryness 
symptoms, who came back for tests, and not just for those 
with positive tests for glandular dysfunction or positive 
autoantibodies.
In conclusion, the prevalence of pSS in Vitória, ES, Brazil, 
was 0.17% according to American-European criteria. It is 
possible that it could be underestimated.
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excluído casos mais leves, atípicos e iniciais da doença. Esse 
rigor, um início insidioso da doença e o amplo espectro de 
manifestações clínicas sistêmicas podem ter subestimado a 
prevalência da síndrome.
A não realização de todos os exames complementares 
incluídos no Consenso Americano-Europeu foi uma limitação 
deste estudo. É possível que indivíduos com teste de Schirmer 
negativo ou À uxo salivar normal apresentem outros testes para 
secura positivos, como Rose Bengal, cintilogra¿ a e sialogra-
¿ a. Fluxo salivar não estimulado e teste de Schirmer foram 
escolhidos por serem de fácil execução e baixo custo. Além 
disso, esses testes mostraram boa correlação e sensitividade 
para o diagnóstico de SS.18
Entre os entrevistados sem sintomas de secura (988 de 
1205), poderia ser possível encontrar SS, uma vez que a 
síndrome “sicca” pode não estar presente na SS precoce e 
em pacientes com predominância de sintomas sistêmicos. 
Entretanto, tal di¿ culdade relaciona-se a aspectos da SS e 
limitação dos critérios classi¿ catórios, explicando como é 
difícil conduzir ensaios clínicos randomizados.
Outra limitação deste estudo foi que apenas 58% dos indi-
víduos entrevistados participaram da segunda fase do estudo, 
isto é, submeteram-se à biopsia de glândula salivar e pesquisa 
de autoanticorpos. A prevalência de SS, considerando-se 
apenas os participantes da segunda fase que se apresentaram 
para os exames complementares, pode ter resultado em uma 
subavaliação da SS na população como um todo. Essa limita-
ção também está presente em outros estudos.5–9 Os indivíduos 
que se submeteram aos exames eram mais velhos que aqueles 
que não participaram da segunda fase deste estudo. Talvez os 
indivíduos mais idosos sejam mais responsáveis ou entendam 
melhor a importância deste estudo. Além disso, é possível 
e esperado que aqueles que não participaram apresentassem 
grau de secura menor. Por isso acreditamos que a prevalência 
não seria tão maior se todos os indivíduos com secura fossem 
incluídos na segunda fase deste estudo. 
Estudos anteriores falharam em determinar as alterações 
histológicas, pois muitos pacientes recusaram se submeter 
à biopsia.4–14 No entanto, a não concordância com exames 
invasivos é comum em grandes estudos populacionais. Um 
aspecto positivo deste estudo foi que a biopsia foi realizada 
em todos os participantes com secura, que retornaram para 
os exames, e não apenas naqueles com testes positivos para 
disfunção glandular ou positivos para os autoanticorpos.
Concluindo, a prevalência de SSp, de acordo com os 
critérios americano-europeus, em Vitória, Espírito Santo, 
Brasil, foi de 0.17%. É possível que tal prevalência tenha 
sido subestimada.
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